Loading…
Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass
Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complica...
Saved in:
Published in: | Endocrine Journal 2024, Vol.71(5), pp.447-460 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c520t-4a7b1f6aa860c22d05caa0795bf0d48a55b64f137eea67d632f2d1005bd45983 |
container_end_page | 460 |
container_issue | 5 |
container_start_page | 447 |
container_title | Endocrine Journal |
container_volume | 71 |
creator | Suzuki, Takashi Kurano, Makoto Isono, Akari Uchino, Takuya Sayama, Yohei Tomomitsu, Honami Mayumi, Daiki Shibayama, Ruriko Sekiguchi, Toru Edo, Naoki Uno-Eder, Kiyoko Uno, Kenji Morita, Koji Ishikawa, Toshio Tsukamoto, Kazuhisa |
description | Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complicated by obesity or diabetes with a history of AP or decreased post-heparin LPL mass. In a patient with a history of AP, SNP rs199953320 resulting in LMF1 nonsense mutation and APOE rs7412 causing apolipoprotein E2 were both found in heterozygous form. Three patients were homozygous for APOA5 rs2075291, and one was heterozygous. ELISA and Western blot analysis of the serum revealed the existence of apolipoprotein A-V in the lipoprotein-free fraction regardless of the presence or absence of rs2075291; furthermore, the molecular weight of apolipoprotein A-V was different depending on the class of lipoprotein or lipoprotein-free fraction. Lipidomics analysis showed increased serum levels of sphingomyelin and many classes of glycerophospholipid; however, when individual patients were compared, the degree of increase in each class of phospholipid among cases did not coincide with the increases seen in total cholesterol and triglycerides. Moreover, phosphatidylcholine, lysophosphatidylinositol, and sphingomyelin levels tended to be higher in patients who experienced AP than those who did not, suggesting that these phospholipids may contribute to the onset of AP. In summary, this study revealed a new disease-causing gene mutation in LMF1, confirmed an association between overlapping of multiple gene mutations and severe hypertriglyceridemia, and suggested that some classes of phospholipid may be involved in the pathogenesis of AP. |
doi_str_mv | 10.1507/endocrj.EJ23-0438 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_df737d40b63b464983bd43999385bea5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_df737d40b63b464983bd43999385bea5</doaj_id><sourcerecordid>2926081151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c520t-4a7b1f6aa860c22d05caa0795bf0d48a55b64f137eea67d632f2d1005bd45983</originalsourceid><addsrcrecordid>eNpdkc1u1DAUhSMEoqXwAGyQJTZsUuzYTpwlqspQVIlN99aNfTPjURIH20M179EHxiEzs2Dj3-8c3XtPUXxk9JZJ2nzFyXoT9rf3PyteUsHVq-KacaFKIQV9XVzTlqlStbK9Kt7FuKeUcyn42-KKKy7qpm6vi5cNTpicITBZ0jlvdjg6A0O-w3CMLhLfk4h_MCDZHWcMKbjtcDQYnM0kEOPHeciKhJY8u7QjYA4JyQyTCQjJpcUirF-Dfyazj6nc4QzBTWRws5-DT7ieISIZIcb3xZsehogfTvtN8fT9_unuR_n4a_Nw9-2xNLKiqRTQdKyvAVRNTVVZKg0AbVrZ9dQKBVJ2tegZbxChbmzNq76yjFLZWSFbxW-Kh9XWetjrObgRwlF7cPrfgw9bDSHPZkBt-4Y3VtCu5p2oRRZnD962LVeyQ5DZ68vqldv5fcCY9OiiwWGACf0h6qqtaqoYkyyjn_9D9_4Q8rij5lTl8gRrluLYSpngYwzYXwpkVC_p61P6eklfL-lnzaeT86Eb0V4U57gzsFmBfUywxQtwbvNs2TAtl-VifSHMDkLG-F_42sls</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3080054178</pqid></control><display><type>article</type><title>Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass</title><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - Open Access English articles</source><creator>Suzuki, Takashi ; Kurano, Makoto ; Isono, Akari ; Uchino, Takuya ; Sayama, Yohei ; Tomomitsu, Honami ; Mayumi, Daiki ; Shibayama, Ruriko ; Sekiguchi, Toru ; Edo, Naoki ; Uno-Eder, Kiyoko ; Uno, Kenji ; Morita, Koji ; Ishikawa, Toshio ; Tsukamoto, Kazuhisa</creator><creatorcontrib>Suzuki, Takashi ; Kurano, Makoto ; Isono, Akari ; Uchino, Takuya ; Sayama, Yohei ; Tomomitsu, Honami ; Mayumi, Daiki ; Shibayama, Ruriko ; Sekiguchi, Toru ; Edo, Naoki ; Uno-Eder, Kiyoko ; Uno, Kenji ; Morita, Koji ; Ishikawa, Toshio ; Tsukamoto, Kazuhisa</creatorcontrib><description>Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complicated by obesity or diabetes with a history of AP or decreased post-heparin LPL mass. In a patient with a history of AP, SNP rs199953320 resulting in LMF1 nonsense mutation and APOE rs7412 causing apolipoprotein E2 were both found in heterozygous form. Three patients were homozygous for APOA5 rs2075291, and one was heterozygous. ELISA and Western blot analysis of the serum revealed the existence of apolipoprotein A-V in the lipoprotein-free fraction regardless of the presence or absence of rs2075291; furthermore, the molecular weight of apolipoprotein A-V was different depending on the class of lipoprotein or lipoprotein-free fraction. Lipidomics analysis showed increased serum levels of sphingomyelin and many classes of glycerophospholipid; however, when individual patients were compared, the degree of increase in each class of phospholipid among cases did not coincide with the increases seen in total cholesterol and triglycerides. Moreover, phosphatidylcholine, lysophosphatidylinositol, and sphingomyelin levels tended to be higher in patients who experienced AP than those who did not, suggesting that these phospholipids may contribute to the onset of AP. In summary, this study revealed a new disease-causing gene mutation in LMF1, confirmed an association between overlapping of multiple gene mutations and severe hypertriglyceridemia, and suggested that some classes of phospholipid may be involved in the pathogenesis of AP.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.EJ23-0438</identifier><identifier>PMID: 38346769</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Apolipoprotein A ; Apolipoprotein A-V (ApoAV) ; Apolipoprotein E ; Apolipoprotein E2 ; Apolipoproteins ; Biochemical analysis ; Cholesterol ; Diabetes mellitus ; Environmental factors ; Genetic analysis ; Genetic factors ; Heparin ; Hypertriglyceridemia ; Lecithin ; Lipase maturation factor 1 (LMF1) ; Lipoprotein lipase ; Lipoproteins ; Molecular weight ; Mutation ; Nonsense mutation ; Pancreatitis ; Phosphatidylcholine ; Phospholipid ; Phospholipids ; Point mutation ; Serum levels ; Single-nucleotide polymorphism ; Sphingomyelin ; Triglycerides ; Whole genome sequencing</subject><ispartof>Endocrine Journal, 2024, Vol.71(5), pp.447-460</ispartof><rights>The Japan Endocrine Society</rights><rights>2024. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c520t-4a7b1f6aa860c22d05caa0795bf0d48a55b64f137eea67d632f2d1005bd45983</cites><orcidid>0009-0003-7596-6440 ; 0000-0002-4166-6664 ; 0009-0002-6299-1770 ; 0000-0001-5579-0773 ; 0000-0002-2953-8491 ; 0009-0006-1854-0496 ; 0009-0009-2969-5655 ; 0000-0002-4673-3897 ; 0000-0002-2596-1145 ; 0009-0001-0531-3706 ; 0000-0002-9270-2450</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38346769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suzuki, Takashi</creatorcontrib><creatorcontrib>Kurano, Makoto</creatorcontrib><creatorcontrib>Isono, Akari</creatorcontrib><creatorcontrib>Uchino, Takuya</creatorcontrib><creatorcontrib>Sayama, Yohei</creatorcontrib><creatorcontrib>Tomomitsu, Honami</creatorcontrib><creatorcontrib>Mayumi, Daiki</creatorcontrib><creatorcontrib>Shibayama, Ruriko</creatorcontrib><creatorcontrib>Sekiguchi, Toru</creatorcontrib><creatorcontrib>Edo, Naoki</creatorcontrib><creatorcontrib>Uno-Eder, Kiyoko</creatorcontrib><creatorcontrib>Uno, Kenji</creatorcontrib><creatorcontrib>Morita, Koji</creatorcontrib><creatorcontrib>Ishikawa, Toshio</creatorcontrib><creatorcontrib>Tsukamoto, Kazuhisa</creatorcontrib><title>Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass</title><title>Endocrine Journal</title><addtitle>Endocr J</addtitle><description>Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complicated by obesity or diabetes with a history of AP or decreased post-heparin LPL mass. In a patient with a history of AP, SNP rs199953320 resulting in LMF1 nonsense mutation and APOE rs7412 causing apolipoprotein E2 were both found in heterozygous form. Three patients were homozygous for APOA5 rs2075291, and one was heterozygous. ELISA and Western blot analysis of the serum revealed the existence of apolipoprotein A-V in the lipoprotein-free fraction regardless of the presence or absence of rs2075291; furthermore, the molecular weight of apolipoprotein A-V was different depending on the class of lipoprotein or lipoprotein-free fraction. Lipidomics analysis showed increased serum levels of sphingomyelin and many classes of glycerophospholipid; however, when individual patients were compared, the degree of increase in each class of phospholipid among cases did not coincide with the increases seen in total cholesterol and triglycerides. Moreover, phosphatidylcholine, lysophosphatidylinositol, and sphingomyelin levels tended to be higher in patients who experienced AP than those who did not, suggesting that these phospholipids may contribute to the onset of AP. In summary, this study revealed a new disease-causing gene mutation in LMF1, confirmed an association between overlapping of multiple gene mutations and severe hypertriglyceridemia, and suggested that some classes of phospholipid may be involved in the pathogenesis of AP.</description><subject>Apolipoprotein A</subject><subject>Apolipoprotein A-V (ApoAV)</subject><subject>Apolipoprotein E</subject><subject>Apolipoprotein E2</subject><subject>Apolipoproteins</subject><subject>Biochemical analysis</subject><subject>Cholesterol</subject><subject>Diabetes mellitus</subject><subject>Environmental factors</subject><subject>Genetic analysis</subject><subject>Genetic factors</subject><subject>Heparin</subject><subject>Hypertriglyceridemia</subject><subject>Lecithin</subject><subject>Lipase maturation factor 1 (LMF1)</subject><subject>Lipoprotein lipase</subject><subject>Lipoproteins</subject><subject>Molecular weight</subject><subject>Mutation</subject><subject>Nonsense mutation</subject><subject>Pancreatitis</subject><subject>Phosphatidylcholine</subject><subject>Phospholipid</subject><subject>Phospholipids</subject><subject>Point mutation</subject><subject>Serum levels</subject><subject>Single-nucleotide polymorphism</subject><subject>Sphingomyelin</subject><subject>Triglycerides</subject><subject>Whole genome sequencing</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdkc1u1DAUhSMEoqXwAGyQJTZsUuzYTpwlqspQVIlN99aNfTPjURIH20M179EHxiEzs2Dj3-8c3XtPUXxk9JZJ2nzFyXoT9rf3PyteUsHVq-KacaFKIQV9XVzTlqlStbK9Kt7FuKeUcyn42-KKKy7qpm6vi5cNTpicITBZ0jlvdjg6A0O-w3CMLhLfk4h_MCDZHWcMKbjtcDQYnM0kEOPHeciKhJY8u7QjYA4JyQyTCQjJpcUirF-Dfyazj6nc4QzBTWRws5-DT7ieISIZIcb3xZsehogfTvtN8fT9_unuR_n4a_Nw9-2xNLKiqRTQdKyvAVRNTVVZKg0AbVrZ9dQKBVJ2tegZbxChbmzNq76yjFLZWSFbxW-Kh9XWetjrObgRwlF7cPrfgw9bDSHPZkBt-4Y3VtCu5p2oRRZnD962LVeyQ5DZ68vqldv5fcCY9OiiwWGACf0h6qqtaqoYkyyjn_9D9_4Q8rij5lTl8gRrluLYSpngYwzYXwpkVC_p61P6eklfL-lnzaeT86Eb0V4U57gzsFmBfUywxQtwbvNs2TAtl-VifSHMDkLG-F_42sls</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Suzuki, Takashi</creator><creator>Kurano, Makoto</creator><creator>Isono, Akari</creator><creator>Uchino, Takuya</creator><creator>Sayama, Yohei</creator><creator>Tomomitsu, Honami</creator><creator>Mayumi, Daiki</creator><creator>Shibayama, Ruriko</creator><creator>Sekiguchi, Toru</creator><creator>Edo, Naoki</creator><creator>Uno-Eder, Kiyoko</creator><creator>Uno, Kenji</creator><creator>Morita, Koji</creator><creator>Ishikawa, Toshio</creator><creator>Tsukamoto, Kazuhisa</creator><general>The Japan Endocrine Society</general><general>Japan Science and Technology Agency</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0009-0003-7596-6440</orcidid><orcidid>https://orcid.org/0000-0002-4166-6664</orcidid><orcidid>https://orcid.org/0009-0002-6299-1770</orcidid><orcidid>https://orcid.org/0000-0001-5579-0773</orcidid><orcidid>https://orcid.org/0000-0002-2953-8491</orcidid><orcidid>https://orcid.org/0009-0006-1854-0496</orcidid><orcidid>https://orcid.org/0009-0009-2969-5655</orcidid><orcidid>https://orcid.org/0000-0002-4673-3897</orcidid><orcidid>https://orcid.org/0000-0002-2596-1145</orcidid><orcidid>https://orcid.org/0009-0001-0531-3706</orcidid><orcidid>https://orcid.org/0000-0002-9270-2450</orcidid></search><sort><creationdate>20240101</creationdate><title>Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass</title><author>Suzuki, Takashi ; Kurano, Makoto ; Isono, Akari ; Uchino, Takuya ; Sayama, Yohei ; Tomomitsu, Honami ; Mayumi, Daiki ; Shibayama, Ruriko ; Sekiguchi, Toru ; Edo, Naoki ; Uno-Eder, Kiyoko ; Uno, Kenji ; Morita, Koji ; Ishikawa, Toshio ; Tsukamoto, Kazuhisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c520t-4a7b1f6aa860c22d05caa0795bf0d48a55b64f137eea67d632f2d1005bd45983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apolipoprotein A</topic><topic>Apolipoprotein A-V (ApoAV)</topic><topic>Apolipoprotein E</topic><topic>Apolipoprotein E2</topic><topic>Apolipoproteins</topic><topic>Biochemical analysis</topic><topic>Cholesterol</topic><topic>Diabetes mellitus</topic><topic>Environmental factors</topic><topic>Genetic analysis</topic><topic>Genetic factors</topic><topic>Heparin</topic><topic>Hypertriglyceridemia</topic><topic>Lecithin</topic><topic>Lipase maturation factor 1 (LMF1)</topic><topic>Lipoprotein lipase</topic><topic>Lipoproteins</topic><topic>Molecular weight</topic><topic>Mutation</topic><topic>Nonsense mutation</topic><topic>Pancreatitis</topic><topic>Phosphatidylcholine</topic><topic>Phospholipid</topic><topic>Phospholipids</topic><topic>Point mutation</topic><topic>Serum levels</topic><topic>Single-nucleotide polymorphism</topic><topic>Sphingomyelin</topic><topic>Triglycerides</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Takashi</creatorcontrib><creatorcontrib>Kurano, Makoto</creatorcontrib><creatorcontrib>Isono, Akari</creatorcontrib><creatorcontrib>Uchino, Takuya</creatorcontrib><creatorcontrib>Sayama, Yohei</creatorcontrib><creatorcontrib>Tomomitsu, Honami</creatorcontrib><creatorcontrib>Mayumi, Daiki</creatorcontrib><creatorcontrib>Shibayama, Ruriko</creatorcontrib><creatorcontrib>Sekiguchi, Toru</creatorcontrib><creatorcontrib>Edo, Naoki</creatorcontrib><creatorcontrib>Uno-Eder, Kiyoko</creatorcontrib><creatorcontrib>Uno, Kenji</creatorcontrib><creatorcontrib>Morita, Koji</creatorcontrib><creatorcontrib>Ishikawa, Toshio</creatorcontrib><creatorcontrib>Tsukamoto, Kazuhisa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Endocrine Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzuki, Takashi</au><au>Kurano, Makoto</au><au>Isono, Akari</au><au>Uchino, Takuya</au><au>Sayama, Yohei</au><au>Tomomitsu, Honami</au><au>Mayumi, Daiki</au><au>Shibayama, Ruriko</au><au>Sekiguchi, Toru</au><au>Edo, Naoki</au><au>Uno-Eder, Kiyoko</au><au>Uno, Kenji</au><au>Morita, Koji</au><au>Ishikawa, Toshio</au><au>Tsukamoto, Kazuhisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass</atitle><jtitle>Endocrine Journal</jtitle><addtitle>Endocr J</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>71</volume><issue>5</issue><spage>447</spage><epage>460</epage><pages>447-460</pages><artnum>EJ23-0438</artnum><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>Severe hypertriglyceridemia is a pathological condition caused by genetic factors alone or in combination with environmental factors, sometimes leading to acute pancreatitis (AP). In this study, exome sequencing and biochemical analyses were performed in 4 patients with hypertriglyceridemia complicated by obesity or diabetes with a history of AP or decreased post-heparin LPL mass. In a patient with a history of AP, SNP rs199953320 resulting in LMF1 nonsense mutation and APOE rs7412 causing apolipoprotein E2 were both found in heterozygous form. Three patients were homozygous for APOA5 rs2075291, and one was heterozygous. ELISA and Western blot analysis of the serum revealed the existence of apolipoprotein A-V in the lipoprotein-free fraction regardless of the presence or absence of rs2075291; furthermore, the molecular weight of apolipoprotein A-V was different depending on the class of lipoprotein or lipoprotein-free fraction. Lipidomics analysis showed increased serum levels of sphingomyelin and many classes of glycerophospholipid; however, when individual patients were compared, the degree of increase in each class of phospholipid among cases did not coincide with the increases seen in total cholesterol and triglycerides. Moreover, phosphatidylcholine, lysophosphatidylinositol, and sphingomyelin levels tended to be higher in patients who experienced AP than those who did not, suggesting that these phospholipids may contribute to the onset of AP. In summary, this study revealed a new disease-causing gene mutation in LMF1, confirmed an association between overlapping of multiple gene mutations and severe hypertriglyceridemia, and suggested that some classes of phospholipid may be involved in the pathogenesis of AP.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>38346769</pmid><doi>10.1507/endocrj.EJ23-0438</doi><tpages>14</tpages><orcidid>https://orcid.org/0009-0003-7596-6440</orcidid><orcidid>https://orcid.org/0000-0002-4166-6664</orcidid><orcidid>https://orcid.org/0009-0002-6299-1770</orcidid><orcidid>https://orcid.org/0000-0001-5579-0773</orcidid><orcidid>https://orcid.org/0000-0002-2953-8491</orcidid><orcidid>https://orcid.org/0009-0006-1854-0496</orcidid><orcidid>https://orcid.org/0009-0009-2969-5655</orcidid><orcidid>https://orcid.org/0000-0002-4673-3897</orcidid><orcidid>https://orcid.org/0000-0002-2596-1145</orcidid><orcidid>https://orcid.org/0009-0001-0531-3706</orcidid><orcidid>https://orcid.org/0000-0002-9270-2450</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0918-8959 |
ispartof | Endocrine Journal, 2024, Vol.71(5), pp.447-460 |
issn | 0918-8959 1348-4540 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_df737d40b63b464983bd43999385bea5 |
source | J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - Open Access English articles |
subjects | Apolipoprotein A Apolipoprotein A-V (ApoAV) Apolipoprotein E Apolipoprotein E2 Apolipoproteins Biochemical analysis Cholesterol Diabetes mellitus Environmental factors Genetic analysis Genetic factors Heparin Hypertriglyceridemia Lecithin Lipase maturation factor 1 (LMF1) Lipoprotein lipase Lipoproteins Molecular weight Mutation Nonsense mutation Pancreatitis Phosphatidylcholine Phospholipid Phospholipids Point mutation Serum levels Single-nucleotide polymorphism Sphingomyelin Triglycerides Whole genome sequencing |
title | Genetic and biochemical analysis of severe hypertriglyceridemia complicated with acute pancreatitis or with low post-heparin lipoprotein lipase mass |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A11%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20and%20biochemical%20analysis%20of%20severe%20hypertriglyceridemia%20complicated%20with%20acute%20pancreatitis%20or%20with%20low%20post-heparin%20lipoprotein%20lipase%20mass&rft.jtitle=Endocrine%20Journal&rft.au=Suzuki,%20Takashi&rft.date=2024-01-01&rft.volume=71&rft.issue=5&rft.spage=447&rft.epage=460&rft.pages=447-460&rft.artnum=EJ23-0438&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.EJ23-0438&rft_dat=%3Cproquest_doaj_%3E2926081151%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c520t-4a7b1f6aa860c22d05caa0795bf0d48a55b64f137eea67d632f2d1005bd45983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3080054178&rft_id=info:pmid/38346769&rfr_iscdi=true |